NCT00593177View on ClinicalTrials.gov

A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Psoriasis Vulgaris
Interventions
DRUG

PTH (1-34) Gel / Placebo Gel

Topical dosing of gel twice daily for eight weeks.

Trial Locations (4)

32174

Advanced Dermatology and Cosmetic Surgery, Ormond Beach

55432

Minnesota Clinical Study Center, Fridley

84124

Dermatology Research Center Inc., Salt Lake City

92123

Therapeutics Clinical Research, San Diego

Sponsors
All Listed Sponsors
collaborator

Therapeutics, Inc.

INDUSTRY

lead

Manhattan Pharmaceuticals

INDUSTRY